NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (https=)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (https=)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (https=) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (https=)
FR (1) FR3150M (https=)
GB (1) GB1080599A (https=)
LU (1) LU45106A1 (https=)
NL (1) NL302572A (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
SG158073A1 (en) 2004-11-26 2010-01-29 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
CA2757373C (en) 2009-04-03 2018-05-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
EA201691430A1 (ru) 2009-06-08 2017-02-28 ЮСиЭл БИЗНЕС ПиЭлСи Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата
MX360062B (es) 2010-10-06 2018-10-22 Ocera Therapeutics Inc Metodos de elaboracion de fenilacetato de l-ornitina.
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
EP3337473A4 (en) 2015-08-18 2019-04-17 Ocera Therapeutics, Inc. TREATMENT AND PREVENTION OF MUSCLE WOUND BY L-ORNITHIN IN COMBINATION WITH AT LEAST ONE PHENYL ACETATE AND PHENYL BUTYRATE
WO2018208677A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
BE641880A (https=) 1964-04-16
LU45106A1 (https=) 1964-02-24
FR3150M (fr) 1965-02-22
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE630640A (https=)
BE616548R (https=)
BE629378A (https=)
BE614159A (https=)
NL302572A (https=)
BE613862A (https=)
BE633369A (https=)
BE632172A (https=)
BE612926A (https=)
BE631769A (https=)
BE631669A (https=)
BE628701A (https=)
BE613529A (https=)
BE630619A (https=)
BE612847A (https=)
BE612464A (https=)
BE630333A (https=)
BE612311A (https=)
BE629944A (https=)
BE629880A (https=)
BE612190A (https=)
BE609543A (https=)
BE629872A (https=)
BE608197A (https=)
BE615849A (https=)